These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11113577)

  • 1. Role of sodium channel inhibition in neuroprotection: effect of vinpocetine.
    Bönöczk P; Gulyás B; Adam-Vizi V; Nemes A; Kárpáti E; Kiss B; Kapás M; Szántay C; Koncz I; Zelles T; Vas A
    Brain Res Bull; 2000 Oct; 53(3):245-54. PubMed ID: 11113577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and non-clinical investigations using positron emission tomography, near infrared spectroscopy and transcranial Doppler methods on the neuroprotective drug vinpocetine: a summary of evidences.
    Vas A; Gulyás B; Szabó Z; Bönöczk P; Csiba L; Kiss B; Kárpáti E; Pánczél G; Nagy Z
    J Neurol Sci; 2002 Nov; 203-204():259-62. PubMed ID: 12417394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymptomatic ischemic cerebrovascular disorders and neuroprotection with vinpocetine.
    Hadjiev D
    Ideggyogy Sz; 2003 May; 56(5-6):166-72. PubMed ID: 12861957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eburnamine derivatives and the brain.
    Vas A; Gulyás B
    Med Res Rev; 2005 Nov; 25(6):737-57. PubMed ID: 16158388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of action of vinpocetine].
    Kiss B; Kárpáti E
    Acta Pharm Hung; 1996 Sep; 66(5):213-24. PubMed ID: 9082841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Human positron emission tomography with oral 11C-vinpocetine].
    Vas A; Christer H; Sóvágó J; Johan S; Cselényi Z; Kiss B; Kárpáti E; Lars F; Gulyás B
    Orv Hetil; 2003 Nov; 144(46):2271-6. PubMed ID: 14702922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of vinpocetine in cerebrovascular diseases.
    Patyar S; Prakash A; Modi M; Medhi B
    Pharmacol Rep; 2011; 63(3):618-28. PubMed ID: 21857073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cerebral uptake and metabolism of (11C) Vinpocetine in monkeys: PET studies].
    Gulyás B; Halldin C; Karlsson P; Chou YH; Swahn CG; Bönöczk P; Farde L
    Orv Hetil; 1999 Jul; 140(30):1687-91. PubMed ID: 10461449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuroprotective drug vinpocetine prevents veratridine-induced [Na+]i and [Ca2+]i rise in synaptosomes.
    Tretter L; Adam-Vizi V
    Neuroreport; 1998 Jun; 9(8):1849-53. PubMed ID: 9665614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroprotective effect of sodium channel blockers in ischemia: the pathomechanism of early ischemic dysfunction].
    Adám-Vizi V
    Orv Hetil; 2000 Jun; 141(23):1279-86. PubMed ID: 10905082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study.
    Szilágyi G; Nagy Z; Balkay L; Boros I; Emri M; Lehel S; Márián T; Molnár T; Szakáll S; Trón L; Bereczki D; Csiba L; Fekete I; Kerényi L; Galuska L; Varga J; Bönöczk P; Vas A; Gulyás B
    J Neurol Sci; 2005 Mar; 229-230():275-84. PubMed ID: 15760651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Vinpocetine on mitochondrial function and neuroprotection in primary cortical neurons.
    Tárnok K; Kiss E; Luiten PG; Nyakas C; Tihanyi K; Schlett K; Eisel UL
    Neurochem Int; 2008 Dec; 53(6-8):289-95. PubMed ID: 18793690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vinpocetine-induced stimulation of calcium-activated potassium currents in rat pituitary GH3 cells.
    Wu SN; Li HF; Chiang HT
    Biochem Pharmacol; 2001 Apr; 61(7):877-92. PubMed ID: 11274974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vinpocetine blockade of sodium channels inhibits the rise in sodium and calcium induced by 4-aminopyridine in synaptosomes.
    Sitges M; Galván E; Nekrassov V
    Neurochem Int; 2005 Jun; 46(7):533-40. PubMed ID: 15843047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions].
    Valikovics A
    Ideggyogy Sz; 2007 Jul; 60(7-8):301-10. PubMed ID: 17713111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cerebral uptake and regional distribution of [11C]-vinpocetin after intravenous administration to healthy men: a PET study].
    Vas A; Sóvágó J; Halldin C; Sandell J; Karlsson P; Kárpáti E; Kiss B; Cselényi Z; Farde L; Gulyás B
    Orv Hetil; 2002 Nov; 143(47):2631-6. PubMed ID: 12532649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single and combined effects of carbamazepine and vinpocetine on depolarization-induced changes in Na+, Ca2+ and glutamate release in hippocampal isolated nerve endings.
    Sitges M; Chiu LM; Nekrassov V
    Neurochem Int; 2006 Jul; 49(1):55-61. PubMed ID: 16621162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects.
    Gulyás B; Halldin C; Sandell J; Karlsson P; Sóvágó J; Kárpáti E; Kiss B; Vas A; Cselényi Z; Farde L
    Acta Neurol Scand; 2002 Dec; 106(6):325-32. PubMed ID: 12460136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine.
    Gulyás B; Halldin C; Sóvágó J; Sandell J; Cselényi Z; Vas A; Kiss B; Kárpáti E; Farde L
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1031-8. PubMed ID: 12173017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vinpocetine. Monograph.
    Altern Med Rev; 2002 Jun; 7(3):240-3. PubMed ID: 12126465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.